Mesoblast Limited: updates and filings

MESONASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$10.89

November 20, 2026Market cap $1.4B

What Ploutos Investor adds for Mesoblast

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from FY2016
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Aug 27, 2026 latest annual
  • Nov 17, 2026Current report (foreign company)
    Form6-K
  • Nov 16, 2026Current report (foreign company)
    Form6-K
  • Nov 12, 2026Current report (foreign company)
    Form6-K
  • Nov 3, 2026Current report (foreign company)
    Form6-K
  • Oct 29, 2026Current report (foreign company)
    Form6-K
  • Oct 16, 2026Current report (foreign company)
    Form6-K
  • Oct 15, 2026Current report (foreign company)
    Form6-K
  • Oct 13, 2026Current report (foreign company)
    Form6-K
  • Sep 24, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Annual report (foreign company)for the period to Jun 30, 2026
    Form20-F
  • Aug 25, 2026Current report (foreign company)
    Form6-K
  • Aug 24, 2026Current report (foreign company)
    Form6-K
  • Aug 18, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 21, 2026Current report (foreign company)
    Form6-K
  • Jul 15, 2026Current report (foreign company)
    Form6-K
  • Jul 14, 2026Current report (foreign company)
    Form6-K
  • Jul 10, 2026Current report (foreign company)
    Form6-K
  • Jul 1, 2026Current report (foreign company)
    Form6-K
  • Jun 25, 2026Current report (foreign company)
    Form6-K
  • Jun 10, 2026Current report (foreign company)
    Form6-K
  • Apr 30, 2026Current report (foreign company)
    Form6-K
  • Apr 29, 2026Current report (foreign company)
    Form6-K
  • Apr 17, 2026Current report (foreign company)
    Form6-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Nov 8, 2005.

The full analysis

What do Mesoblast's filings show?

The filings are where every one of Mesoblast's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.